Mauna Kea Announces Review of Strategic Alternatives
19 Noviembre 2024 - 10:45AM
Business Wire
Regulatory News:
Mauna Kea Technologies (Euronext Growth: ALMKT),
inventor of Cellvizio®, the multidisciplinary probe and
needle-based confocal laser endomicroscopy (p/nCLE) platform, today
announced that its Board of Directors, under the leadership of
Chairman and CEO Sacha Loiseau, has authorized the management team
to initiate a review of strategic alternatives for the Company.
The objective of this process is to evaluate a broad range of
options to maximize shareholder value, ensure operational
stability, and secure the necessary capital to unlock Cellvizio’s
long-term commercial potential. Additionally, the Company aims to
safeguard its broad intellectual property portfolio and optimize
its valuation to the fullest extent.
The Company has retained Bucephale Finance as financial advisor
to assist in its review of strategic alternatives.
Mauna Kea's management will regularly update its shareholders
and strategic partners on its progress.
***
About Mauna Kea Technologies
Mauna Kea Technologies is a global medical device company that
manufactures and sells Cellvizio®, the real-time in vivo cellular
imaging platform. This technology uniquely delivers in vivo
cellular visualization which enables physicians to monitor the
progression of disease over time, assess point-in-time reactions as
they happen in real time, classify indeterminate areas of concern,
and guide surgical interventions. The Cellvizio® platform is used
globally across a wide range of medical specialties and is making a
transformative change in the way physicians diagnose and treat
patients. For more information, visit www.maunakeatech.com.
Disclaimer
This press release contains forward-looking statements about
Mauna Kea Technologies and its business. All statements other than
statements of historical fact included in this press release,
including, but not limited to, statements regarding Mauna Kea
Technologies' financial condition, business, strategies, plans and
objectives for future operations are forward-looking statements.
Mauna Kea Technologies believes that these forward-looking
statements are based on reasonable assumptions. However, no
assurance can be given that the expectations expressed in these
forward-looking statements will be achieved. These forward-looking
statements are subject to numerous risks and uncertainties,
including those described in Chapter 2 of Mauna Kea Technologies'
2023 Annual Report filed with the Autorité des marchés financiers
(AMF) on April 30, 2024, which is available on the Company's
website (www.maunakeatech.fr), as well as the risks associated with
changes in economic conditions, financial markets and the markets
in which Mauna Kea Technologies operates. The forward-looking
statements contained in this press release are also subject to
risks that are unknown to Mauna Kea Technologies or that Mauna Kea
Technologies does not currently consider material. The occurrence
of some or all of these risks could cause the actual results,
financial condition, performance or achievements of Mauna Kea
Technologies to differ materially from those expressed in the
forward-looking statements. This press release and the information
contained herein do not constitute an offer to sell or subscribe
for, or the solicitation of an order to buy or subscribe for,
shares of Mauna Kea Technologies in any jurisdiction in which such
offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such
jurisdiction. The distribution of this press release may be
restricted in certain jurisdictions by local law. Persons into
whose possession this document comes are required to comply with
all local regulations applicable to this document.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241119839597/en/
Mauna Kea Technologies investors@maunakeatech.com
NewCap - Investor Relations Aurélie Manavarere / Thomas
Grojean +33 (0)1 44 71 94 94 maunakea@newcap.eu
Mauna Kea Technologies (EU:ALMKT)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Mauna Kea Technologies (EU:ALMKT)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024